Results for tag: "Convalescent Plasma Therapy"

Within the biopharmaceutical industry, Convalescent Plasma Therapy (CPT) is a form of treatment where plasma, the liquid component of blood containing antibodies, is taken from patients who have recovered from an infectious disease and transfused into individuals currently battling the same ailment. This therapeutic approach leverages the concept of passive immunity, wherein these antibodies can help the recipient's immune system fight off the infection more effectively. Historically, CPT has been employed in response to various outbreaks and has seen a resurgence in interest in recent times due to new health challenges. The market for convalescent plasma spans blood collection, processing, storage, and distribution, with a heavy emphasis on safety and efficacy. Regulatory oversight ensures that this biopharmaceutical intervention meets strict standards before it can be administered to patients. As for companies and organizations involved in the convalescent plasma therapy market, some of the key players include the American Red Cross, CSL Behring, Grifols, Octapharma, and Takeda Pharmaceuticals. These companies and organizations are engaged in the collection and supply of convalescent plasma, as well as research and development to enhance and broaden the therapeutic applications of this treatment modality. Show Less Read more